TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Mar 7, 4:16 PM ET

Hughes Eric A 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-05
Hughes Eric A
See "Remarks"
Transactions
  • Award

    Restricted Share Units

    2025-03-05+78,61678,616 total
    Ordinary Shares (78,616 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on March 5, 2025, with 19,654 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028 and March 5, 2029.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4